Advanced Systemic Mastocytosis clinical trials

Explore recruiting advanced systemic mastocytosis clinical trials.

Recruiting advanced systemic mastocytosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Systemic Mastocytosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, open-label, 2-arm study evaluating BLU-263 as monotherapy and in combination with azacitidine, in patients with KIT altered hematologic malignancies

Belgium, Spain, France, Netherlands, Norway, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2 Open-Label, Multicenter Clinical Study of The Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Profiles of CGT9486 as a Single Agent in Patients with Advanced Systemic Mastocytosis

Spain, France, Netherlands, Norway, Belgium, Austria +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Advanced Systemic Mastocytosis trials by city

Advanced Systemic Mastocytosis clinical trials

Recruiting advanced systemic mastocytosis studies right now

Avapritinib Rollover Study

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Also recruiting in Europe

A Phase 1/2, open-label, 2-arm study evaluating BLU-263 as monotherapy and in combination with azacitidine, in patients with KIT altered hematologic malignancies

A Phase 2 Open-Label, Multicenter Clinical Study of The Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Profiles of CGT9486 as a Single Agent in Patients with Advanced Systemic Mastocytosis

Advanced Systemic Mastocytosis trials by city

Other conditions